MedTrace Logo

ION US Post-Approval Study

NCT01422889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1120

Last updated 2016-02-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.

Conditions

Interventions

DEVICE

ION™ Coronary Stent System

This study is intended to evaluate the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System across a range of institutions and physician users to observe and assess subject outcomes and technology performance in a real-world setting.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Louis A Cannon, MD · Northern Michigan Hospital

  • Carey D Kimmelstiel, MD · Tufts Medical Center

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-06-30
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422889 on ClinicalTrials.gov